PetIQ, Inc. (PETQ) Financials
Stock symbol PETQ is outdated, potentially delisted? Maybe it is available on other exchange?
PETQ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 894.4 million | 634.1 million |
| March 31, 2024 | 875.2 million | 637.4 million |
| Dec. 31, 2023 | 868.2 million | 645.2 million |
| Sept. 30, 2023 | 857.1 million | 617.9 million |
PETQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | 56.2 million | 2.8 million |
| March 31, 2024 | -86.7 million | 2.6 million |
| Dec. 31, 2023 | -5.8 million | 1.4 million |
| Sept. 30, 2023 | 48.2 million | 2.9 million |
PETQ Net Income
No data available :(
PETQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 84.1 million | 447.8 million | 17.6 million |
| March 31, 2024 | 25.4 million | 449.8 million | 20.0 million |
| Dec. 31, 2023 | 116.4 million | 452.1 million | 21.9 million |
| Sept. 30, 2023 | 124.6 million | 448.6 million | 16.3 million |
PETQ Shares Outstanding
PETQ Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | 1.7 million | - | 59.3 million | - |
| March 31, 2024 | 1.6 million | - | 49.7 million | - |
| Dec. 31, 2023 | 2.9 million | 1.1 million | 42.0 million | 45.6 million |
| Sept. 30, 2023 | 2.1 million | - | 55.0 million | - |
PETQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 328.9 million | 240.7 million |
| March 31, 2024 | 308.4 million | 233.9 million |
| Dec. 31, 2023 | 219.9 million | 175.9 million |
| Sept. 30, 2023 | 277.0 million | 204.4 million |
PETQ Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PETQ
Price: $30.98
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.37 USD
P/E Ratio: 83.73
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 192400
Ebitda: 2.8 millionMarket Capitalization: 926.6 million